Imaging of experimental prostate cancer with pretargeted immunoPET and FDG-PET
2012-01-01 van Rij, C; Frielink, C; Sharkey, R; Mcbride, W; Rossi, E; Chang, Ch; Franssen, G; Oyen, W; Goldenberg, D; Boerman, O
Bevacizumab treatment reduces targeting of anti-epidermal growth factor receptor and anti-insulin-like growth factor 1 receptor antibodies
2012-01-01 Heskamp, S; van Laarhoven, H; Molkenboer-Kuenen, J; Oyen, W; van der Graaf, W; Boerman, O
ADDRESSING CLINICAL CHALLENGES IN TARGETED THERAPIES WITH ADVANCED IMAGING
2012-01-01 Oyen, W
Pre-steady-state and transport-associated currents in the GABA cotransporter rGAT1 are simply related
2002-01-01 Peres, A; Giovannardi, S; Binda, F; Bossi, E; Fesce, RICCARDO GIUSEPPE
Tc-99m-labeled C5a and C5a-des-Arg(74) for infection imaging.
2001-01-01 Rennen, Hj; Boerman, Oc; Oyen, W; Monk, Pn; Cain, Sa; Corstens, Fh
Pretargeted immunoPET for imaging human colonic cancer in a mouse model
2011-01-01 Schoffelen, R; Franssen, Gm; Mcbride, Wj; Disselhorst, Ja; Sharkey, Rm; Laverman, P; van der Graaf, Wta; Oyen, W; Goldenberg, Dm; Boerman, Oc
Increased tolerance to forearm ischemia-reperfusion in patients with type 1 diabetes mellitus
2005-01-01 Engbersen, R; Oyen, W; Meijer, P; Tack, Cj; Smits, P; Rongen, Ga
Bevacizumab prevents effective targeting of anti-epidermal growth factor and anti-insulin-like growth factor 1 receptor antibodies
2012-01-01 Heskamp, S; van Laarhoven, Hwm; Molkenboer-Kuenen, Jdm; van der Graaf, Wta; Oyen, W; Boerman, Oc
Comparison of multiple (semi-)automatic segmentation methods for delineation of head and neck tumours in repetitive FLT-PET/CT imaging
2012-01-01 Arens, Aij; Troost, Egc; Hoeben, Baw; Grootjans, W; Maessen, Aw; Huisman, K; Lee, Ja; Visvikis, D; Bussink, J; Oyen, W; Kaanders, Jham; Visser, Ep
Quantification of the Pancreatic Beta Cell Mass with (111)Inexendin in Patients with Type 1 Diabetes and Healthy Controls
2013-01-01 van der Weg, W; Brom, M; Janssen, Mjr; Behe, M; Oyen, W; Tack, Cjj; Boerman, Oc; Gotthardt, M
SPECT/fluorescence dual-modality imaging of carcinoembryonic antigen-expressing tumors: a pretargeting study
2013-01-01 Rijpkema, M; Sharkey, R; Bos, D; Mcbride, W; Oyen, W; Goldenberg, D; Boerman, O
Cost-effectiveness of FDG-PET/CT for cytologically indeterminate thyroid nodules
2013-01-01 Vriens, D; Adang, Emm; Netea-Maier, Rt; Smit, Jwa; de Wilt, Jhw; Oyen, W; de Geus-Oei, Lf
Dynamics of IGF-1R expression during endocrine breast cancer treatment
2013-01-01 Heskamp, S; Boerman, Oc; Molkenboer-Kuenen, Jdm; Oyen, W; van der Graaf, Wta; van Laarhoven, Hwm
SPECT/CT Imaging of Programmed-Death Ligand 1 Expression of Tumors and Antigen-Presenting Cells
2015-01-01 Heskamp, S; Hobo, W; Molkenboer-Kuenen, Jdm; Olive, D; Oyen, W; Dolstra, H; Boerman, Oc
PET and SPECT imaging of rheumatoid arthritis with radiolabeled anti-FAP antibody correlates with severity of arthritis
2014-01-01 Laverman, P; Gerrits, D; van der Geest, T; Koenders, M; Nayak, T; Freimoser-Grundschober, A; Klein, C; Oyen, W; Boerman, O
Pharmacokinetic analysis of tumor heterogeneity using FDG-PET
2010-01-01 Vriens, D; de Geus-Oei, Lf; Oyen, W; Visser, E
TRANSIENT STOP-FLOW ARM ARTERIAL-VENOUS EQUILIBRIUM PRESSURE MEASUREMENT: DETERMINATION OF PRECISION OF THE TECHNIQUE
2014-01-01 Aya, Hd; Rhodes, A; Fletcher, N; Grounds, M; Cecconi, M
The role of FDG-pet in the selection of patients with colorectal liver metastases
2007-01-01 Ruers, V; Wiering, B; Dekker, H; Krabbe, P; Oyen, W
THERE IS NO ADDITIONAL ROLE FOR ELT-PET/CT SCAN IN PEDIATRIC BRAINSTEM TUMORS
2010-01-01 Janssens, Gorj; Gidding, Cem; van Lindert, Ej; Schieving, J; Oyen, W
Radioimmunotherapy of advanced renal cell carcinoma patients with Lutetium-177 labeled monoclonal antibody cG250
2007-01-01 Oosterwijk, E; Stillebroer, A; Boerman, Oc; De Weijer, Kjm; Hendrickx, Bw; Oyen, W; Mulders, Pfa
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Imaging of experimental prostate cancer with pretargeted immunoPET and FDG-PET | 1-gen-2012 | van Rij, C; Frielink, C; Sharkey, R; Mcbride, W; Rossi, E; Chang, Ch; Franssen, G; Oyen, W; Goldenberg, D; Boerman, O | |
| Bevacizumab treatment reduces targeting of anti-epidermal growth factor receptor and anti-insulin-like growth factor 1 receptor antibodies | 1-gen-2012 | Heskamp, S; van Laarhoven, H; Molkenboer-Kuenen, J; Oyen, W; van der Graaf, W; Boerman, O | |
| ADDRESSING CLINICAL CHALLENGES IN TARGETED THERAPIES WITH ADVANCED IMAGING | 1-gen-2012 | Oyen, W | |
| Pre-steady-state and transport-associated currents in the GABA cotransporter rGAT1 are simply related | 1-gen-2002 | Peres, A; Giovannardi, S; Binda, F; Bossi, E; Fesce, RICCARDO GIUSEPPE | |
| Tc-99m-labeled C5a and C5a-des-Arg(74) for infection imaging. | 1-gen-2001 | Rennen, Hj; Boerman, Oc; Oyen, W; Monk, Pn; Cain, Sa; Corstens, Fh | |
| Pretargeted immunoPET for imaging human colonic cancer in a mouse model | 1-gen-2011 | Schoffelen, R; Franssen, Gm; Mcbride, Wj; Disselhorst, Ja; Sharkey, Rm; Laverman, P; van der Graaf, Wta; Oyen, W; Goldenberg, Dm; Boerman, Oc | |
| Increased tolerance to forearm ischemia-reperfusion in patients with type 1 diabetes mellitus | 1-gen-2005 | Engbersen, R; Oyen, W; Meijer, P; Tack, Cj; Smits, P; Rongen, Ga | |
| Bevacizumab prevents effective targeting of anti-epidermal growth factor and anti-insulin-like growth factor 1 receptor antibodies | 1-gen-2012 | Heskamp, S; van Laarhoven, Hwm; Molkenboer-Kuenen, Jdm; van der Graaf, Wta; Oyen, W; Boerman, Oc | |
| Comparison of multiple (semi-)automatic segmentation methods for delineation of head and neck tumours in repetitive FLT-PET/CT imaging | 1-gen-2012 | Arens, Aij; Troost, Egc; Hoeben, Baw; Grootjans, W; Maessen, Aw; Huisman, K; Lee, Ja; Visvikis, D; Bussink, J; Oyen, W; Kaanders, Jham; Visser, Ep | |
| Quantification of the Pancreatic Beta Cell Mass with (111)Inexendin in Patients with Type 1 Diabetes and Healthy Controls | 1-gen-2013 | van der Weg, W; Brom, M; Janssen, Mjr; Behe, M; Oyen, W; Tack, Cjj; Boerman, Oc; Gotthardt, M | |
| SPECT/fluorescence dual-modality imaging of carcinoembryonic antigen-expressing tumors: a pretargeting study | 1-gen-2013 | Rijpkema, M; Sharkey, R; Bos, D; Mcbride, W; Oyen, W; Goldenberg, D; Boerman, O | |
| Cost-effectiveness of FDG-PET/CT for cytologically indeterminate thyroid nodules | 1-gen-2013 | Vriens, D; Adang, Emm; Netea-Maier, Rt; Smit, Jwa; de Wilt, Jhw; Oyen, W; de Geus-Oei, Lf | |
| Dynamics of IGF-1R expression during endocrine breast cancer treatment | 1-gen-2013 | Heskamp, S; Boerman, Oc; Molkenboer-Kuenen, Jdm; Oyen, W; van der Graaf, Wta; van Laarhoven, Hwm | |
| SPECT/CT Imaging of Programmed-Death Ligand 1 Expression of Tumors and Antigen-Presenting Cells | 1-gen-2015 | Heskamp, S; Hobo, W; Molkenboer-Kuenen, Jdm; Olive, D; Oyen, W; Dolstra, H; Boerman, Oc | |
| PET and SPECT imaging of rheumatoid arthritis with radiolabeled anti-FAP antibody correlates with severity of arthritis | 1-gen-2014 | Laverman, P; Gerrits, D; van der Geest, T; Koenders, M; Nayak, T; Freimoser-Grundschober, A; Klein, C; Oyen, W; Boerman, O | |
| Pharmacokinetic analysis of tumor heterogeneity using FDG-PET | 1-gen-2010 | Vriens, D; de Geus-Oei, Lf; Oyen, W; Visser, E | |
| TRANSIENT STOP-FLOW ARM ARTERIAL-VENOUS EQUILIBRIUM PRESSURE MEASUREMENT: DETERMINATION OF PRECISION OF THE TECHNIQUE | 1-gen-2014 | Aya, Hd; Rhodes, A; Fletcher, N; Grounds, M; Cecconi, M | |
| The role of FDG-pet in the selection of patients with colorectal liver metastases | 1-gen-2007 | Ruers, V; Wiering, B; Dekker, H; Krabbe, P; Oyen, W | |
| THERE IS NO ADDITIONAL ROLE FOR ELT-PET/CT SCAN IN PEDIATRIC BRAINSTEM TUMORS | 1-gen-2010 | Janssens, Gorj; Gidding, Cem; van Lindert, Ej; Schieving, J; Oyen, W | |
| Radioimmunotherapy of advanced renal cell carcinoma patients with Lutetium-177 labeled monoclonal antibody cG250 | 1-gen-2007 | Oosterwijk, E; Stillebroer, A; Boerman, Oc; De Weijer, Kjm; Hendrickx, Bw; Oyen, W; Mulders, Pfa |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista2157
Data di pubblicazione
- 2020 - 2025111
- 2010 - 20191343
- 2000 - 2009591
- 1990 - 1999111
- 1988 - 19891
Editore
- Nature Publishing Group4
- s.n4
- ICRS3
- Blackwell1
Rivista
- EUROPEAN UROLOGY. SUPPLEMENTS124
- GASTROENTEROLOGY123
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...120
- THE JOURNAL OF UROLOGY111
- DIGESTIVE AND LIVER DISEASE100
- THE JOURNAL OF NUCLEAR MEDICINE80
- ANNALS OF THE RHEUMATIC DISEASES69
- RADIOTHERAPY AND ONCOLOGY59
- ANNALS OF ONCOLOGY57
- JOURNAL OF CLINICAL ONCOLOGY45
Keyword
- Myelodysplastic syndrome8
- Survival4
- biomimetic3
- Mitochondrial ferritin3
- osteochondral3
- Prognosis3
- scaffold3
- Sideroblastic anemia3
- viscosupplementation3
- COLONOSCOPIC SURVEILLANCE2
Lingua
- eng798
- ita24
- und6
Accesso al fulltext
- no fulltext2104
- reserved51
- open2